Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
52,510,682
-
Shares change
-
+12,109,472
-
Total reported value, excl. options
-
$101,343,483
-
Value change
-
+$24,232,593
-
Put/Call ratio
-
79.4%
-
Number of buys
-
47
-
Number of sells
-
-23
-
Price
-
$1.93
Significant Holders of TRANSENTERIX INC - COM NEW (TRXC) as of Q4 2017
102 filings reported holding TRXC - TRANSENTERIX INC - COM NEW as of Q4 2017.
TRANSENTERIX INC - COM NEW (TRXC) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52,510,682 shares
.
Largest 10 shareholders include Aisling Capital LLC (9,889,352 shares), SV Health Investors, LLC (7,546,692 shares), JPMORGAN CHASE & CO (7,126,606 shares), Vanguard Group Inc (5,231,279 shares), Redmile Group, LLC (5,017,790 shares), MASTERS CAPITAL MANAGEMENT LLC (3,875,000 shares), StepStone Group LP (3,032,625 shares), BlackRock Inc. (1,760,266 shares), ROYAL BANK OF CANADA (1,037,621 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (955,695 shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.